1 day ago · Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry ...

2 days ago · TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI with a Buy rating and price target of $74, up from $58, following the closed of the Ambry acquisition. The deal affords Tempus with a ...

On Wednesday, TD Cowen reinitiated coverage on Tempus AI Inc (NASDAQ:TEM) with a Buy rating, increasing the price target to $74 from a previous target. The stock, currently trading at $61.85, has ...

2 days ago · Check Out Our Latest Analysis on TEM Tempus AI Stock Up 0.5 %. MarketBeat Week in Review – 01/20 - 01/24; Shares of TEM stock opened at $61.85 on Wednesday. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

1 day ago · On Wednesday, TD (TSX: TD) Cowen reinitiated coverage on Tempus AI Inc (NASDAQ: TEM) with a Buy rating, increasing the price target to $74 from a previous target.The stock, currently trading at $61.85, has shown remarkable momentum with an 83.2% gain year-to-date. According to InvestingPro data, analyst targets for TEM range from $50 to $70, with a consensus recommendation leaning towards Buy.

1 day ago · On Wednesday, TD Cowen reiterated its buy rating for Tempus AI’s shares, while increasing the price target to $74 after the company successfully closed its acquisition of Ambry Genetics, a deal ...

1 day ago · TD Cowen reaffirmed a "buy" rating and set a $74.00 price objective (up previously from $58.00) on shares of Tempus AI in a research note on Wednesday. Piper Sandler reissued a "neutral" rating and issued a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th.

2 days ago · NEW YORK – TD Cowen on Wednesday reinstated coverage of Tempus AI with a Buy rating and a price target of $74, up from its previous target of $58. In a note to investors, TD Cowen analyst Dan Brennan highlighted the company's recently closed $600 million acquisition of Ambry Genetics, noting that ...

2 days ago · TD Cowen: Announces: Buy: $74.00-Mark Schappel: Loop Capital: Lowers: Buy: $52.00: $57.00: Ryan MacDonald: ... Revenue Growth: Tempus AI's revenue growth over a period of 3 months has been ...

1 day ago · Analysts at TD Cowen just upgraded the AI stock to a buy rating, with a price target of $74. According to the firm, the latest acquisition gives Tempus a $300 profitable germline testing lab.